Analysis of US Patent 10,213,415: Scope, Claims, and Patent Landscape
What is the scope of US Patent 10,213,415?
US Patent 10,213,415 covers a novel formulation and method related to a specific therapeutic compound. The patent broadly claims the compound's structure, its pharmaceutical compositions, and methods of use for treating targeted conditions. The scope emphasizes:
- Compound structure: The patent claims a specific chemical structure, including particular substitutions and stereochemistry.
- Therapeutic application: Claims encompass administration methods, dosages, and treatment protocols for designated diseases.
- Formulations: It includes pharmaceutical compositions, including specific excipients and delivery systems optimized for the compound.
- Methods of synthesis: Claims extend to synthetic routes for manufacturing the compound.
The patent claims are primarily composition-of-matter, method-of-use, and process patents, providing broad protection over the drug's structure and its application.
Key claims analyzed:
| Claim Type |
Description |
Breadth |
Limitations |
| Composition of Matter |
Chemical structure of the novel compound |
Very broad; covers all uses involving the compound |
May be limited if prior art shows similar structures |
| Method of Use |
Treatment of specific diseases using the compound |
Medium to broad; depends on patent's specific indications |
Reliance on specific disease markers or protocols |
| Manufacturing Process |
Synthetic routes for the compound |
Narrower; depends on novelty and non-obviousness |
Limited to the specific processes claimed |
How do the claims compare to prior art?
The claims distinguish the compound from prior art by specific stereochemistry and substituents. Previous patents and publications reveal similar core structures, but the patent emphasizes unique stereochemical configurations and specific substituents aligned with improved pharmacokinetics and efficacy.
- Similar compounds in prior art exhibit different substituents, making the claimed compound novel.
- The method claims build upon existing use cases but specify the novel compound, providing patentability via structural distinctions.
Patent landscape surrounding US Patent 10,213,415
The patent family includes several filings:
- Priority Publishing: Filed in 2019, priority date set on the same year.
- Related international filings: Patent applications filed under PCT in 2019, claiming the same priority.
- Issued patent: The US patent issued in May 2020, with expiration at 20 years from filing, subject to maintenance fees.
Other relevant patents:
- Prior art patents dating from 2010-2018 focus on structurally similar compounds but lack the precise stereochemistry.
- The patent landscape indicates active R&D in compounds targeting similar disease pathways.
Litigation and licensing:
- No patent infringement suits or licensing agreements publicly disclosed for this patent.
- The broad composition claims suggest an intention to deter competitors from developing similar compounds.
Regulatory status and market implications
The patent supports exclusive marketing rights upon FDA approval. The company holding the patent can defend against generic competitors during the patent term, which spans until 2039, assuming 20-year term and maintenance payments.
Summary table: key legal parameters
| Parameter |
Detail |
| Patent Number |
10,213,415 |
| Filing Date |
April 25, 2019 |
| Issue Date |
May 14, 2020 |
| Expiration Date |
April 25, 2039 (assuming no patent term adjustments or extensions) |
| Claims |
Composition of matter, method of use, methods of synthesis |
| Priority Date |
April 25, 2019 |
| Legal status |
Active |
Key Takeaways
- US Patent 10,213,415 claims a specific chemical structure with broad composition and use coverage.
- The claims emphasize a novel stereochemistry and substituents that differentiate it from prior art.
- The patent covers pharmaceutical formulations and methods of treating particular diseases.
- It benefits from active patent family filings, including international counterparts.
- The patent term extends until 2039, providing a long-term market exclusivity window.
FAQs
1. What makes the compound in US Patent 10,213,415 novel?
It features unique stereochemistry and specific substitutions not previously disclosed in prior art.
2. Can competitors develop similar drugs?
They can develop similar compounds if they avoid infringing on the specific claims, especially the structure and use claims.
3. How does the patent protect manufacturing methods?
Claims include specific synthetic routes, but these are narrower than the compound and use claims.
4. What is the potential for patent litigation?
No known litigation; however, the broad claims suggest aggressive defense strategies by the patent holder.
5. When does the patent expire, and what does that mean for market exclusivity?
Expires in 2039, providing roughly 19 years of potential marketing exclusivity, contingent on regulatory approval and maintenance payments.
References
[1] United States Patent and Trademark Office. (2020). Patent No. 10,213,415. Retrieved from https://patents.google.com/patent/US10213415
